Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder.

abstract：:ABSTRACT A report of neuroleptic malignant syndrome (NMS) in an adolescent patient with bipolar disorder is presented, and findings from a literature review of 35 child and adolescent cases (presenting before age 19) are compared with the reported experience in adults. Fever, rigidity, altered mental status, and tachy...

journal_title：Journal of child and adolescent psychopharmacology

authors： Steingard R,Khan A,Gonzalez A,Herzog DB

更新日期：1992-10-01 00:00:00

abstract：OBJECTIVE:Few studies of psychotropic medication use among children and adolescents address the effectiveness of this medication, as it is typically used in naturalistic treatment settings. The objective of this study was to investigate psychotropic medication use among children and adolescents treated in system of car...

journal_title：Journal of child and adolescent psychopharmacology

authors： Drilea SK,Jowers K,Lichtenstein C,Hale M,Blau G,Stromberg S

更新日期：2013-02-01 00:00:00

abstract：:The increasing use of olanzapine for treating adolescent patients has brought with it greater awareness of the recognized side effects of this medication, especially weight gain. Of the reports of glucose dysregulation related to olanzapine therapy, only a few pertain to adolescents. We present five cases: two youths ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Bloch Y,Vardi O,Mendlovic S,Levkovitz Y,Gothelf D,Ratzoni G

更新日期：2003-04-01 00:00:00

abstract：:Bipolar disorder (BP) in youth is an impairing psychiatric disorder associated with high rates of relapse and recurrence. High rates of psychiatric and medical co-morbidities account for additional illness burden in pediatric BP. The elevated risk of overweight and obesity in this population is of particular concern. ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Goldstein TR,Goldstein BI,Mantz MB,Bailey B,Douaihy A

更新日期：2011-06-01 00:00:00

abstract：:This open-label study examined the potential efficacy of paroxetine in the treatment of children and adolescents diagnosed with dysthymia over a period of 3 months. Seven subjects were evaluated by the Hamilton Depression Rating Scale (HAM-D), by the Clinical Global Impression Severity of Illness Scale (CGI-S), and th...

journal_title：Journal of child and adolescent psychopharmacology

authors： Nobile M,Bellotti B,Marino C,Molteni M,Battaglia M

更新日期：2000-07-01 00:00:00

abstract：:A 10-year-old boy with a history of heart transplantation had a potentially life-threatening decrease in his cyclosporine (CSA) blood levels during administration of bupropion. Subsequently he had an increase in CSA levels while receiving methylphenidate. These occurrences represent potential drug-drug interactions in...

journal_title：Journal of child and adolescent psychopharmacology

authors： Lewis BR,Aoun SL,Bernstein GA,Crow SJ

更新日期：2001-07-01 00:00:00

abstract：OBJECTIVE:Irritability is both a normal developmental phenomenon and a common psychiatric symptom in children. In psychiatric nosology, a distinction is made between chronic and episodic irritability. This study examines the validity of this distinction. METHODS:A sample of 776 youths received Diagnostic and Statistic...

journal_title：Journal of child and adolescent psychopharmacology

authors： Leibenluft E,Cohen P,Gorrindo T,Brook JS,Pine DS

更新日期：2006-08-01 00:00:00

abstract：:A preliminary clinical observation suggests the possibility of changes in valproate level when coadministered with guanfacine. Two pediatric inpatients (8 and 9 years of age) were treated with valproic acid and guanfacine concurrently. In one child, when guanfacine was tapered and discontinued, the plasma valproate co...

journal_title：Journal of child and adolescent psychopharmacology

authors： Ambrosini PJ,Sheikh RM

更新日期：1998-01-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to conduct a prospective safety and tolerability study of aripiprazole for the treatment of tics in children and adolescents with Tourette's disorder (TD). METHOD:Eleven subjects (10 males) with TD (age 9-19 years, mean 13.36, standard deviation [SD] 3.33) who did not respond or wer...

journal_title：Journal of child and adolescent psychopharmacology

authors： Lyon GJ,Samar S,Jummani R,Hirsch S,Spirgel A,Goldman R,Coffey BJ

更新日期：2009-12-01 00:00:00

abstract：: Objective: To examine the role of Guanfacine Extended Release (GXR) in the management of behavioral disturbances in patients with Prader-Willi Syndrome (PWS). Methods: Twenty from a total of 27 individuals with genetically conf...

journal_title：Journal of child and adolescent psychopharmacology

authors： Singh D,Wakimoto Y,Filangieri C,Pinkhasov A,Angulo M

更新日期：2019-05-01 00:00:00

abstract：: Objective: To explore blinded observational outcomes in the Treatment of Severe Childhood Aggression (TOSCA) study. Methods: During a 9-week acute trial, children with severe physical aggression and attention-deficit/hyperactiv...

journal_title：Journal of child and adolescent psychopharmacology

authors： Grondhuis SN,Farmer CA,Arnold LE,Gadow KD,Findling RL,Molina BSG,Kolko DJ,Buchan-Page KA,Rice RR , Jr,Butter EM,Aman MG

更新日期：2020-02-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to examine the association between the CYP2D6 and CYP2C19 genotype-predicted combined phenotypes and short-term measures of psychotropic efficacy and toxicity. METHODS:A rater-blinded, retrospective genotype association design examined a cohort of hospitalized pediatric psychiatric ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Prows CA,Nick TG,Saldaña SN,Pathak S,Liu C,Zhang K,Daniels ZS,Vinks AA,Glauser TA

更新日期：2009-08-01 00:00:00

abstract：:Autism spectrum disorder (ASD) is commonly associated with a host of challenging behaviors. Pharmacotherapy is indicated if psychosocial and educational interventions fail. Atypical antipsychotics have the strongest evidence base so far, with both risperidone and aripiprazole being FDA approved. Unfortunately, their u...

journal_title：Journal of child and adolescent psychopharmacology

authors： Naguy A

更新日期：2017-06-01 00:00:00

abstract：OBJECTIVE:This functional magnetic resonance imaging (fMRI) study investigated the effects of pharmacotherapy on brain function underlying affect dysregulation and cognitive function in pediatric bipolar disorder (PBD). METHOD:Healthy controls (HC) (n=14; mean age =14.1 ± 2.4 years) and unmedicated PBD patients with m...

journal_title：Journal of child and adolescent psychopharmacology

authors： Pavuluri MN,Passarotti AM,Parnes SA,Fitzgerald JM,Sweeney JA

更新日期：2010-10-01 00:00:00

abstract：OBJECTIVE:This study evaluates pediatric antidepressant prescribing practices of Nebraska clinicians. METHODS:Surveys were sent in July, 2005, to 1,521 prescribing clinicians throughout Nebraska to assess pediatric antidepressant use along with any practice changes following the U.S. Food and Drug Administration (FDA)...

journal_title：Journal of child and adolescent psychopharmacology

authors： Bhatia SK,Rezac AJ,Vitiello B,Sitorius MA,Buehler BA,Kratochvil CJ

更新日期：2008-02-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to investigate the side effect risks from using one or more psychiatric medications (including antipsychotics, antidepressants, α-2 agonists, benzodiazepines, mood stabilizers, and stimulants) among a national cohort of children and adolescents. METHODS:A questionnaire survey wa...

journal_title：Journal of child and adolescent psychopharmacology

authors： Hilt RJ,Chaudhari M,Bell JF,Wolf C,Koprowicz K,King BH

更新日期：2014-03-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to compare the pharmacokinetics of immediate-release methylphenidate (MPH) in preschool and school-aged children with attention-deficit/hyperactivity disorder (ADHD). METHODS:Preschool children 4-5 years (n = 14) and school-aged children 6-8 years (n = 9) with diagnoses of ADHD were...

journal_title：Journal of child and adolescent psychopharmacology

authors： Wigal SB,Gupta S,Greenhill L,Posner K,Lerner M,Steinhoff K,Wigal T,Kapelinski A,Martinez J,Modi NB,Stehli A,Swanson J

更新日期：2007-04-01 00:00:00

abstract：BACKGROUND:Despite the increased recognition of attention deficit hyperactivity disorder (ADHD) in adolescents, few controlled studies have assessed treatments for this age group. Adolescent issues, such as embarrassment at receiving medication at school and experimentation with abusable substances, have accelerated ef...

journal_title：Journal of child and adolescent psychopharmacology

authors： Bostic JQ,Biederman J,Spencer TJ,Wilens TE,Prince JB,Monuteaux MC,Sienna M,Polisner DA,Hatch M

更新日期：2000-10-01 00:00:00

abstract：OBJECTIVE:Co-occurrence of substance use and bipolar disorders is both common and associated with poor treatment response and greater functional impairment than either disorder alone. The neurophysiological correlates of this co-morbidity however, remain unclear. In this pilot study, we compared brain morphometry betwe...

journal_title：Journal of child and adolescent psychopharmacology

authors： Jarvis K,DelBello MP,Mills N,Elman I,Strakowski SM,Adler CM

更新日期：2008-12-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to investigate the course of autistic symptoms, using a quantitative measure of core autistic traits, among risperidone-treated children who participated in a 10 year life course longitudinal study. METHODS:Parents completed surveys of intervention history, as well as serial sym...

journal_title：Journal of child and adolescent psychopharmacology

authors： Marrus N,Underwood-Riordan H,Randall F,Zhang Y,Constantino JN

更新日期：2014-11-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to investigate the link between the use of specific types of substances and suicidality in adolescent inpatients with schizophrenia and schizoaffective disorder. METHODS:We performed a 10-year naturalistic retrospective study of 178 adolescent inpatients diagnosed as suffering from ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Shoval G,Sever J,Sher L,Diller R,Apter A,Weizman A,Zalsman G

更新日期：2006-12-01 00:00:00

abstract：OBJECTIVE:Tourette syndrome (TS) is a neuropsychiatric disorder associated with motor and vocal tics. Some people with TS have reported using alternative or complementary medicine (CAM), including nutritional supplements to control their tics. In a recent national survey, approximately 40% of people reported having use...

journal_title：Journal of child and adolescent psychopharmacology

authors： Mantel BJ,Meyers A,Tran QY,Rogers S,Jacobson JS

更新日期：2004-01-01 00:00:00

abstract：OBJECTIVE:Different methylphenidate (MPH) formulations, immediate release (IR) or extended release (ER), have been developed to treat Attention-Deficit/Hyperactivity Disorder (ADHD). A better use of these formulations, with a proper choice of their timing, dosage, and combination, can help to attain optimal therapeutic...

journal_title：Journal of child and adolescent psychopharmacology

authors： Soufsaf S,Robaey P,Bonnefois G,Nekka F,Li J

更新日期：2019-04-01 00:00:00

abstract：:The diagnosis of bipolar spectrum disorders (BPSD) is difficult to evaluate in child and adolescent populations. The current study examines whether commonly used behavior checklists- the Child Behavior Checklist, Teacher Report Form, and the Youth Self-Report form-are clinically useful in making a differential diagnos...

journal_title：Journal of child and adolescent psychopharmacology

authors： Kahana SY,Youngstrom EA,Findling RL,Calabrese JR

更新日期：2003-01-01 00:00:00

abstract：:Although there are reports on their use for the treatment of enuresis, we present three pediatric cases with serotonin-selective reuptake inhibitor (SSRI)-induced enuresis. Because SSRIs continue to be commonly prescribed in the pediatric population, the need to monitor for the possibility of enuresis precipitated by ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Hergüner S,Kilinçaslan A,Görker I,Tüzün U

更新日期：2007-06-01 00:00:00

abstract：OBJECTIVE:Methylphenidate (MPH) is commonly used to treat attention-deficit/hyperactivity disorder (ADHD) in all children, including those with velocardiofacial syndrome (VCFS). Yet concerns have been raised regarding its safety and efficacy in VCFS. The goal of this study was to examine the safety and efficacy of MPH ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Green T,Weinberger R,Diamond A,Berant M,Hirschfeld L,Frisch A,Zarchi O,Weizman A,Gothelf D

更新日期：2011-12-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to evaluate the efficacy and safety of acute quetiapine monotherapy in adolescents with schizophrenia. METHODS:Patients ages 13-17 years with an American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR) diagnosis ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Findling RL,McKenna K,Earley WR,Stankowski J,Pathak S

更新日期：2012-10-01 00:00:00

abstract：:This study examined the contributions of childhood symptom dimensions and aspects of methylphenidate (MPH) treatment to the prediction of young adult outcomes in boys who were referred to a child psychiatry outpatient clinic. They were diagnosed with hyperkinetic reaction of childhood/minimal brain dysfunction, and gi...

journal_title：Journal of child and adolescent psychopharmacology

authors： Paternite CE,Loney J,Salisbury H,Whaley MA

更新日期：1999-01-01 00:00:00

abstract：:In the last 15 years, there has been a marked increase in the number of available stimulant formulations with the emphasis on long-acting formulations, and the introduction of several novel delivery systems such as orally dissolving tablets, chewable tablets, extended-release liquid formulations, transdermal patches, ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Steingard R,Taskiran S,Connor DF,Markowitz JS,Stein MA

更新日期：2019-06-01 00:00:00

abstract：BACKGROUND:Prior studies have suggested that inhibited temperament may be associated with an increased risk for developing anxiety or mood disorder, including bipolar disorder. However, the neurobiological basis for this increased risk is unknown. The aim of this study was to examine temperament in symptomatic and asym...

journal_title：Journal of child and adolescent psychopharmacology

authors： Kim E,Garrett A,Boucher S,Park MH,Howe M,Sanders E,Kelley RG,Reiss AL,Chang KD,Singh MK

更新日期：2017-04-01 00:00:00